Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma

Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma

BACKGROUND AND OBJECTIVES: The failure of existing treatments for liver cancer has recently been attributed to the existence of cancer stem cells, which are difficult to kill using current drugs due to their chemoresistant properties as well as their ability to stimulate neoangiogenesis. The aim of...

Full description

Bibliographic Details
Main Authors: Ciprian Tomuleasa, Olga Soritau, Eva Fischer-Fodor, Teodora Pop, Sergiu Susman, Ofelia Mosteanu, Bobe Petrushev, Mihaela Aldea, Monica Acalovschi, Alexanru Irimie, Gabriel Kacso
Format: Article
Language:English
Published: Elsevier 2011-04-01
Series:Hematology/Oncology and Stem Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1658387611500391

Internet

http://www.sciencedirect.com/science/article/pii/S1658387611500391

Similar Items